Edit
SONIRE Therapeutics Inc.
https://www.sonire-therapeutics.com/Last activity: 15.04.2026
Probably Closed
Sonire develops non-invasive cancer treatment device using High-Intensity Focused Ultrasound (HIFU). HIFU creates cavitation bubbles that simultaneously visualize and treat the tissue, targeting with high accuracy by robot guidance and high efficiency by multi-channel/point irradiation, without requirement for anesthesia. Sonire applies this therapy for the treatment of intractable cancers, such as pancreatic cancer, and establish new treatment modalities in combination with drugs.
Location: Japan, Tokyo
Investors 4
| Date | Name | Website |
| - | MAKOTO CAP... | mkto-capit... |
| - | FFG Ventur... | ffg-ventur... |
| - | Fast Track... | us.fasttra... |
| - | J-Startup | j-startup.... |
Mentions in press and media 4
| Date | Title | Description |
| 15.04.2026 | Sonire Therapeutics Closes $18 Million Series A Financing | PALO ALTO, CA, Sonire Therapeutics, a U.S. based clinical-stage medical device company, announced $18M in Series A financing led by Santé Ventures. >> Click here for more funding data on Sonire Therapeutics >> To export Sonire... |
| 15.04.2026 | Top Startup and Tech Funding News – April 15 2025 | It’s Wednesday, April 15, 2026, and we’re back with today’s top startup and tech funding news. Today’s rounds highlight a clear shift toward AI infrastructure, agentic systems, next-generation therapeutics, and space-based intelligence. As ... |
| 15.04.2026 | Sonire Therapeutics Raises $18M to Transform Pancreatic Cancer Treatment | What You Should Know The Raise: Clinical-stage medical device company Sonire Therapeutics has announced an $18M Series A financing round. The round was led by Santé Ventures, with participation from Fast Track Initiative (FTI), Nomura SPARX... |
| - | Sonire Therapeutics | “Sonia Therapeutics Co., Ltd. is developing a next-generation high-intensity focused ultrasound (HIFU) treatment device using acoustic engineering (ultrasound) technology created from the academia that conducts cutting-edge research.” |